News IDEXX Laboratories, Inc.

Stocks

IDXX

US45168D1046

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 00:00:00 09/09/2026 +04			5-day change	1st Jan Change
520.21 ^USD	-2.83%		-4.58%	-23.11%

08-18	IDEXX Laboratories, Inc. - Analyst/Investor Day
08-11	IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment	MT

All News

Mentions Relevance

08-31	IDEXX Laboratories to Participate in Morgan Stanley 24th Annual Global Healthcare Conference	BU
08-18	IDEXX Laboratories, Inc. - Analyst/Investor Day
08-11	IDEXX Laboratories Launches Catalyst proBNP Test for In-Clinic Cardiac Disease Assessment	MT
08-11	IDEXX Expands Catalyst Platform into Cardiac Disease with First and Only Dual-Species Point-of-Care NT-proBNP Test	BU
08-11	Idexx Laboratories Launches Catalyst Probnp Test for Cardiac Assessment in Cats and Dogs	CI
08-11	Barclays Adjusts Price Target on IDEXX Laboratories to $710 From $800, Keeps Overweight Rating	MT
08-05	Jefferies Adjusts Price Target on IDEXX Laboratories to $795 From $792	MT
08-05	Citigroup Adjusts Price Target on IDEXX Laboratories to $670 From $650	MT
08-05	UBS Adjusts Price Target on IDEXX Laboratories to $670 From $620, Maintains Neutral Rating	MT
08-05	IDEXX Laboratories : Quarterly Report for Quarter Ending June 30, 2026 (Form 10-Q)	PU
08-05	Tranche Update on IDEXX Laboratories, Inc.'s Equity Buyback Plan announced on August 13, 1999.	CI
08-04	Idexx Laboratories, Inc. Updates Earnings Guidance for 2026	CI
08-04	IDEXX Laboratories, Inc., Q2 2026 Earnings Call, Aug 04, 2026
08-04	IDEXX Laboratories, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-04	IDEXX Laboratories' Q2 Earnings, Revenue Increase; 2026 Outlook Updated	MT
08-04	Veterinary diagnostics maker IDEXX raises annual profit forecast on pet healthcare testing demand	RE
08-04	IDEXX Laboratories' Q2 Comparable Earnings, Revenue Increase; 2026 Outlook Updated	MT
08-04	Earnings Flash (IDXX) IDEXX Laboratories Posts Q2 Adjusted EPS $4.07, vs. FactSet Est of $3.94	MT
08-04	Earnings Flash (IDXX) IDEXX Laboratories, Inc. Reports Q2 Revenue $1.22B, vs. FactSet Est of $1.20B	MT
08-04	IDEXX Laboratories : Earnings snapshot Q2 2026	PU
08-04	Idexx: Q2 Earnings Snapshot	AQ
08-04	IDEXX Laboratories Announces Second Quarter Results	BU
07-28	IDEXX Releases 2025 Corporate Responsibility Report, Highlighting Progress Against Its Goals	BU
07-27	UBS Cuts IDEXX Laboratories Price Target to $620 From $640, Maintains Neutral Rating	MT
07-13	Leerink Partners Adjusts IDEXX Laboratories Price Target to $715 From $725, Maintains Outperform Rating	MT